R & D Internal Auditing - A Key Consideration for Pharmaceutical Companies
Investments in research and development (R&D) by globally acting pharmaceutical corporations are substantial reflecting the complexity and risks associated with identifying and developing novel and innovative medicines. The sheer amount of these investments are evidence that R&D is seen as a key contributor to long term and sustainable business performance.